Align Technology, Inc. (ALGN)
USD 154.24
(-5.94%)
USD 154.24
(-5.94%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 445.05 Million USD | 23.09% |
| 2022 | 361.57 Million USD | -53.17% |
| 2021 | 772.02 Million USD | -56.53% |
| 2020 | 1.77 Billion USD | 301.08% |
| 2019 | 442.77 Million USD | 10.63% |
| 2018 | 400.23 Million USD | 72.95% |
| 2017 | 231.41 Million USD | 22.0% |
| 2016 | 189.68 Million USD | 31.71% |
| 2015 | 144.02 Million USD | -1.24% |
| 2014 | 145.83 Million USD | 126.82% |
| 2013 | 64.29 Million USD | 9.55% |
| 2012 | 58.69 Million USD | -12.03% |
| 2011 | 66.71 Million USD | -10.15% |
| 2010 | 74.25 Million USD | 337.47% |
| 2009 | -31.26 Million USD | -139.09% |
| 2008 | 79.98 Million USD | 123.9% |
| 2007 | 35.72 Million USD | 202.18% |
| 2006 | -34.96 Million USD | -2574.38% |
| 2005 | 1.41 Million USD | -83.88% |
| 2004 | 8.76 Million USD | 143.57% |
| 2003 | -20.12 Million USD | 70.46% |
| 2002 | -68.12 Million USD | 30.11% |
| 2001 | -97.47 Million USD | -9.83% |
| 2000 | -88.74 Million USD | -475.72% |
| 1999 | -15.41 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 105.02 Million USD | -15.31% |
| 2024 Q3 | 115.96 Million USD | 20.09% |
| 2024 Q2 | 96.56 Million USD | -8.06% |
| 2023 Q4 | 124.01 Million USD | 2.13% |
| 2023 Q1 | 87.79 Million USD | 110.17% |
| 2023 Q2 | 111.81 Million USD | 27.35% |
| 2023 Q3 | 121.42 Million USD | 8.6% |
| 2023 FY | 445.05 Million USD | 23.09% |
| 2022 Q3 | 72.7 Million USD | -35.55% |
| 2022 FY | 361.57 Million USD | -53.17% |
| 2022 Q4 | 41.77 Million USD | -42.54% |
| 2022 Q2 | 112.8 Million USD | -16.01% |
| 2022 Q1 | 134.29 Million USD | -29.67% |
| 2021 Q3 | 180.96 Million USD | -9.39% |
| 2021 Q4 | 190.96 Million USD | 5.52% |
| 2021 Q2 | 199.71 Million USD | -0.33% |
| 2021 Q1 | 200.37 Million USD | 26.03% |
| 2021 FY | 772.02 Million USD | -56.53% |
| 2020 FY | 1.77 Billion USD | 301.08% |
| 2020 Q4 | 158.98 Million USD | 14.08% |
| 2020 Q2 | -40.6 Million USD | -102.67% |
| 2020 Q1 | 1.51 Billion USD | 1151.94% |
| 2020 Q3 | 139.37 Million USD | 443.26% |
| 2019 Q2 | 147.14 Million USD | 104.8% |
| 2019 Q1 | 71.84 Million USD | -26.23% |
| 2019 Q3 | 102.52 Million USD | -30.32% |
| 2019 Q4 | 121.26 Million USD | 18.28% |
| 2019 FY | 442.77 Million USD | 10.63% |
| 2018 Q1 | 95.86 Million USD | 834.0% |
| 2018 FY | 400.23 Million USD | 72.95% |
| 2018 Q2 | 106.1 Million USD | 10.68% |
| 2018 Q3 | 100.87 Million USD | -4.93% |
| 2018 Q4 | 97.39 Million USD | -3.45% |
| 2017 Q1 | 69.42 Million USD | 45.78% |
| 2017 FY | 231.41 Million USD | 22.0% |
| 2017 Q2 | 69.17 Million USD | -0.35% |
| 2017 Q3 | 82.55 Million USD | 19.34% |
| 2017 Q4 | 10.26 Million USD | -87.57% |
| 2016 Q2 | 50.14 Million USD | 23.68% |
| 2016 FY | 189.68 Million USD | 31.71% |
| 2016 Q4 | 47.62 Million USD | -7.29% |
| 2016 Q3 | 51.36 Million USD | 2.43% |
| 2016 Q1 | 40.54 Million USD | -17.04% |
| 2015 Q4 | 48.87 Million USD | 76.99% |
| 2015 FY | 144.02 Million USD | -1.24% |
| 2015 Q1 | 36.17 Million USD | -8.51% |
| 2015 Q2 | 31.35 Million USD | -13.34% |
| 2015 Q3 | 27.61 Million USD | -11.91% |
| 2014 FY | 145.83 Million USD | 126.82% |
| 2014 Q2 | 35.6 Million USD | 9.73% |
| 2014 Q1 | 32.44 Million USD | -23.52% |
| 2014 Q3 | 38.24 Million USD | 7.44% |
| 2014 Q4 | 39.54 Million USD | 3.38% |
| 2013 Q3 | 34.53 Million USD | 17.79% |
| 2013 Q1 | -41.98 Million USD | -539.2% |
| 2013 FY | 64.29 Million USD | 9.55% |
| 2013 Q4 | 42.42 Million USD | 22.83% |
| 2013 Q2 | 29.32 Million USD | 169.84% |
| 2012 Q3 | 24.32 Million USD | -14.64% |
| 2012 Q4 | 9.55 Million USD | -60.7% |
| 2012 Q1 | 20.98 Million USD | 2.62% |
| 2012 FY | 58.69 Million USD | -12.03% |
| 2012 Q2 | 28.49 Million USD | 35.78% |
| 2011 FY | 66.71 Million USD | -10.15% |
| 2011 Q1 | 15.84 Million USD | 59.93% |
| 2011 Q2 | 11.16 Million USD | -29.54% |
| 2011 Q3 | 19.26 Million USD | 72.59% |
| 2011 Q4 | 20.44 Million USD | 6.15% |
| 2010 Q4 | 9.9 Million USD | -41.09% |
| 2010 FY | 74.25 Million USD | 337.47% |
| 2010 Q2 | 32.6 Million USD | 118.37% |
| 2010 Q1 | 14.93 Million USD | 29.92% |
| 2010 Q3 | 16.81 Million USD | -48.42% |
| 2009 Q2 | 4.54 Million USD | 72.42% |
| 2009 FY | -31.26 Million USD | -139.09% |
| 2009 Q3 | -49.94 Million USD | -1198.83% |
| 2009 Q4 | 11.49 Million USD | 123.01% |
| 2009 Q1 | 2.63 Million USD | -95.98% |
| 2008 Q4 | 65.49 Million USD | 1170.04% |
| 2008 FY | 79.98 Million USD | 123.9% |
| 2008 Q3 | 5.15 Million USD | 27.97% |
| 2008 Q2 | 4.03 Million USD | -24.02% |
| 2008 Q1 | 5.3 Million USD | -6.42% |
| 2007 Q1 | 6.97 Million USD | 140.41% |
| 2007 Q2 | 13.61 Million USD | 95.16% |
| 2007 Q3 | 9.46 Million USD | -30.53% |
| 2007 FY | 35.72 Million USD | 202.18% |
| 2007 Q4 | 5.66 Million USD | -40.08% |
| 2006 Q4 | -17.26 Million USD | -67.34% |
| 2006 FY | -34.96 Million USD | -2574.38% |
| 2006 Q3 | -10.32 Million USD | -295.4% |
| 2006 Q1 | -4.76 Million USD | -1002.27% |
| 2006 Q2 | -2.61 Million USD | 45.21% |
| 2005 FY | 1.41 Million USD | -83.88% |
| 2005 Q1 | 1.86 Million USD | 66.19% |
| 2005 Q2 | 538 Thousand USD | -71.12% |
| 2005 Q4 | 528 Thousand USD | 134.83% |
| 2005 Q3 | -1.51 Million USD | -381.78% |
| 2004 FY | 8.76 Million USD | 143.57% |
| 2004 Q1 | 557 Thousand USD | 23.23% |
| 2004 Q2 | 3.77 Million USD | 577.2% |
| 2004 Q3 | 3.31 Million USD | -12.04% |
| 2004 Q4 | 1.12 Million USD | -66.21% |
| 2003 FY | -20.12 Million USD | 70.46% |
| 2003 Q2 | -7.75 Million USD | 11.65% |
| 2003 Q4 | 452 Thousand USD | 121.08% |
| 2003 Q1 | -8.78 Million USD | 36.88% |
| 2003 Q3 | -2.14 Million USD | 72.37% |
| 2002 Q1 | -18.5 Million USD | 10.7% |
| 2002 FY | -68.12 Million USD | 30.11% |
| 2002 Q4 | -13.91 Million USD | 17.63% |
| 2002 Q3 | -16.89 Million USD | 10.24% |
| 2002 Q2 | -18.81 Million USD | -1.7% |
| 2001 Q2 | -22.29 Million USD | 30.24% |
| 2001 Q1 | -31.95 Million USD | 0.0% |
| 2001 FY | -97.47 Million USD | -9.83% |
| 2001 Q4 | -20.71 Million USD | 7.93% |
| 2001 Q3 | -22.5 Million USD | -0.94% |
| 2000 FY | -88.74 Million USD | -475.72% |
| 2000 Q1 | -8.08 Million USD | 0.0% |
| 1999 FY | -15.41 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -81.66 Million USD | 644.987% |
| Cerus Corporation | -37.48 Million USD | 1287.156% |
| OrthoPediatrics Corp. | -20.97 Million USD | 2221.927% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 4162.447% |
| Talis Biomedical Corporation | -62 Million USD | 817.746% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 3376.544% |
| Inogen, Inc. | -102.44 Million USD | 534.414% |
| Spectral AI, Inc. | -20.85 Million USD | 2234.137% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 832.284% |
| CVRx, Inc. | -41.19 Million USD | 1180.252% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | -69418.241% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 5128.847% |
| Orthofix Medical Inc. | -151.39 Million USD | 393.968% |
| Venus Concept Inc. | -37.25 Million USD | 1294.773% |
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 822.278% |
| Bioventus Inc. | -156.23 Million USD | 384.87% |
| BrainsWay Ltd. | -4.19 Million USD | 10704.074% |
| Envoy Medical, Inc. | -29.9 Million USD | 1588.073% |
| electroCore, Inc. | -18.83 Million USD | 2463.03% |
| IceCure Medical Ltd | -14.65 Million USD | 3137.49% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 945.048% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 3337.875% |
| MaxCyte, Inc. | -37.92 Million USD | 1273.57% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 3852.716% |
| Nexalin Technology, Inc. | -4.64 Million USD | 9673.69% |
| PAVmed Inc | -64.17 Million USD | 793.499% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 948.253% |
| RxSight, Inc. | -48.6 Million USD | 1015.596% |
| Sight Sciences, Inc. | -55.54 Million USD | 901.219% |
| SI-BONE, Inc. | -43.33 Million USD | 1126.982% |
| TELA Bio, Inc. | -46.66 Million USD | 1053.739% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 853.842% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 998.607% |
| LivaNova PLC | 17.54 Million USD | -2436.493% |
| 908 Devices Inc. | -36.39 Million USD | 1322.707% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 338.458% |
| Nemaura Medical Inc. | -14.14 Million USD | 3246.644% |
| NeuroPace, Inc. | -32.95 Million USD | 1450.446% |
| LENSAR, Inc. | -14.38 Million USD | 3194.299% |
| Apyx Medical Corporation | -18.71 Million USD | 2478.309% |
| Cutera, Inc. | -162.83 Million USD | 373.319% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 4209.446% |
| BioSig Technologies, Inc. | -29.04 Million USD | 1632.499% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 638.368% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 2114.817% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | -556.992% |
| Axonics, Inc. | -6.08 Million USD | 7410.332% |
| Outset Medical, Inc. | -172.79 Million USD | 357.558% |
| IRIDEX Corporation | -9.57 Million USD | 4750.502% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 520.27% |
| IRadimed Corporation | 17.19 Million USD | -2488.605% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 5498.508% |
| INVO Bioscience, Inc. | -8.03 Million USD | 5639.197% |
| Telesis Bio, Inc. | -47.72 Million USD | 1032.556% |
| Viemed Healthcare, Inc. | 10.24 Million USD | -4244.948% |
| Varex Imaging Corporation | -47.7 Million USD | 1033.025% |
| Quipt Home Medical Corp. | -2.78 Million USD | 16086.099% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 4043.408% |
| Pulmonx Corporation | -60.84 Million USD | 831.478% |
| Dynatronics Corporation | -2.69 Million USD | 16597.382% |
| Modular Medical, Inc. | -17.47 Million USD | 2647.527% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 4008.431% |
| Semler Scientific, Inc. | 20.58 Million USD | -2062.236% |
| InMode Ltd. | 197.91 Million USD | -124.866% |
| Bruker Corporation | 427.2 Million USD | -4.179% |
| Cytosorbents Corporation | -28.5 Million USD | 1661.184% |
| DexCom, Inc. | 541.5 Million USD | 17.811% |
| Viveve Medical, Inc. | -22.02 Million USD | 2120.488% |
| ZimVie Inc. | -393.28 Million USD | 213.164% |
| Movano Inc. | -29.28 Million USD | 1619.834% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 3763.591% |
| Nexalin Technology, Inc. | -4.64 Million USD | 9673.69% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | -69418.241% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 299.924% |
| Profound Medical Corp. | -28.56 Million USD | 1657.818% |
| Insulet Corporation | 206.3 Million USD | -115.731% |
| enVVeno Medical Corporation | -23.51 Million USD | 1992.554% |
| Surmodics, Inc. | -11.54 Million USD | 3955.944% |
| iCAD, Inc. | -4.84 Million USD | 9282.03% |
| Nuwellis, Inc. | -20.2 Million USD | 2302.251% |
| Biotricity, Inc. | -14.09 Million USD | 3257.685% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 460.641% |
| Aethlon Medical, Inc. | -12.2 Million USD | 3745.533% |
| InspireMD, Inc. | -19.91 Million USD | 2334.651% |
| PAVmed Inc. | -64.17 Million USD | 793.499% |
| BIOLASE, Inc. | -20.63 Million USD | 2257.101% |
| Beyond Air, Inc. | -60.24 Million USD | 838.775% |
| FONAR Corporation | 10.56 Million USD | -4111.567% |
| AxoGen, Inc. | -21.71 Million USD | 2149.424% |
| Vivani Medical, Inc. | -25.65 Million USD | 1834.964% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | -1460.768% |
| Inari Medical, Inc. | -1.63 Million USD | 27303.729% |
| UFP Technologies, Inc. | 44.92 Million USD | -890.68% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | 8771.555% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 6837.91% |
| Tenon Medical, Inc. | -15.58 Million USD | 2956.383% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 2985.084% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 1359.601% |
| AdaptHealth Corp. | -678.89 Million USD | 165.555% |
| Sintx Technologies, Inc. | -8.25 Million USD | 5488.703% |
| NanoVibronix, Inc. | -3.71 Million USD | 12092.805% |
| Quanterix Corporation | -32.33 Million USD | 1476.424% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 4043.408% |
| Sensus Healthcare, Inc. | 485 Thousand USD | -91663.505% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 245.094% |
| TransMedics Group, Inc. | -25.02 Million USD | 1878.22% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 2110.812% |
| NeuroMetrix, Inc. | -6.52 Million USD | 6916.048% |
| Hyperfine, Inc. | -44.23 Million USD | 1106.042% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 666.932% |
| Biomerica, Inc. | -5.97 Million USD | 7544.848% |
| Bone Biologics Corporation | -8.94 Million USD | 5073.364% |
| AVITA Medical, Inc. | -39.16 Million USD | 1236.261% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 4571.147% |
| Silk Road Medical, Inc | -55.74 Million USD | 898.402% |